Details regarding risk factors, onset, and outcomes for denosumab-related osteonecrosis (DRONJ) are sparse. This study examines the clinical characteristics and operative and non-operative therapeutic outcomes in patients with DRONJ not previously exposed to other antiresorptives.
http://ift.tt/2jyBF36
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου